Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Aptose Biosciences Q2 EPS $(0.15) Misses $(0.14) Estimate

Aptose Biosciences (NASDAQ:APTO) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.14) by 7.14 percent. This is a 28.57 percent increase over losses of $(0.21) per share
byBenzinga Newsdesk
August 3, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Aptose Biosciences (NASDAQ:APTO) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.14) by 7.14 percent. This is a 28.57 percent increase over losses of $(0.21) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

SAP: Q3 Earnings Insights

By Benzinga Insights
Today, 2:23 AM
  SAP (NYSE:SAP) reported its Q3 earnings results on Thursday, October 21, 2021 at 01:00 AM. Here's what investors need to know about the announcement. Earnings SAP beat their estimated earnings by 33.99%, which surprised analysts.

SAP